Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrabotulinumtoxinA vs OnabotulinumtoxinA for Upper Facial Expression Lines
NCT05840445Phase 4Completed
- Sponsor
- Instituto de Oftalmología Fundación Conde de Valenciana
- Start
- Jun 2020
- Primary completion
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in rhytides, sponsored by Instituto de Oftalmología Fundación Conde de Valenciana. Started Jun 2020; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
rhytides
Beyond the preview
Go deeper on NCT05840445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05840445.